GEXVal CEO Nominated for the Executive of the Year, Citeline Pharma Intelligence Awards Japan 2023

GEXVal Inc.
September 13, 2023

GEXVal CEO Nominated for the Executive of the Year,
Citeline Pharma Intelligence Awards Japan 2023

We are pleased to announce that Juran Kato, PhD, founder, President and CEO of GEXVal Inc., has been nominated for the prestigious Executive of the Year Award at the Citeline Pharma Intelligence Awards Japan 2023. The award ceremony will be held on October 17th at The Palace Hotel Tokyo, Japan.

Event Details
https://www.citeline.com/ja-jp/awards/citelinepharmaintelligenceawards

GEXVal is dedicated to generating extra value by delivering innovative and life-changing treatment options to improve health and quality of life (QoL) for patients and families affected by rare and untreatable diseases.

This nomination reflects Dr. Kato's exemplary leadership and GEXVal's unwavering commitment to pioneering research and development.

About Citeline Pharma Intelligence Awards Japan
The Citeline Pharma Intelligence Awards Japan is the Japanese counterpart of the globally recognized industry awards, boasting a nearly two-decades legacy in the UK.  These awards celebrate outstanding advancements and innovations in Japanese pharmaceutical and biotechnology sectors, underscoring Japan’s contributions to the global healthcare landscape.  

For further information:
Head of Corporate office
Atsushi Sugizaki
info@gexval.com